Technical know‐how in stereotactic ablative radiotherapy (SABR)
Open Access
- 3 March 2016
- journal article
- Published by Wiley in Journal of Medical Radiation Sciences
- Vol. 63 (1) , 5-8
Abstract
Stereotactic ablative radiotherapy (SABR) is an addition to the armamentarium against cancer. The technical requirements for SABR are very stringent, given its very narrow therapeutic window. However, when the principles are strictly followed, it is possible to deliver SABR to extracranial tumours safely and effectively.Keywords
This publication has 9 references indexed in Scilit:
- A comparison of three different VMAT techniques for the delivery of lung stereotactic ablative radiation therapyJournal of Medical Radiation Sciences, 2016
- The effect of beam arrangements and the impact of non‐coplanar beams on the treatment planning of stereotactic ablative radiation therapy for early stage lung cancerJournal of Medical Radiation Sciences, 2015
- Guidelines for safe practice of stereotactic body (ablative) radiation therapyJournal of Medical Imaging and Radiation Oncology, 2015
- Sub-millimeter spine position monitoring for stereotactic body radiotherapy using offline digital tomosynthesisRadiotherapy and Oncology, 2015
- Algorithms Used in Heterogeneous Dose Calculations Show Systematic Differences as Measured With the Radiological Physics Center's Anthropomorphic Thorax Phantom Used for RTOG CredentialingInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- The Canadian Association of Radiation Oncology Scope of Practice Guidelines for Lung, Liver and Spine Stereotactic Body RadiotherapyClinical Oncology, 2012
- Impact of Immobilization on Intrafraction Motion for Spine Stereotactic Body Radiotherapy Using Cone Beam Computed TomographyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- An analysis of patient positioning during stereotactic lung radiotherapy performed without rigid external immobilizationRadiotherapy and Oncology, 2012
- Stereotactic body radiation therapy: a novel treatment modalityNature Reviews Clinical Oncology, 2009